Featured Stories
BIAL and Medis entered into a partnership for innovative medicines for the central nervous system
BIAL and Medis announce that they have entered into an exclusive partner-ship on two BIAL's proprietary medicines eslicarbazepine acetate and opicapone.
Read More
Heartily for a better tomorrow, interview with Marija Delimar, director of Medis Adria d.o.o., Croatia
In more than 30 years of business, Medis has established important cooperation with leading global pharmaceutical and biotechnological companies. We talked with...
Read More